Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 36

BillFederalSenateIn Committee
To review domestic biopharmaceutical manufacturing capabilities in order to improve public health and medical preparedness and response capabilities and domestic biopharmaceutical manufacturing capabilities.
About This Bill
Committee
Latest Action · January 24, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
January 24, 2023
Cosponsors (1)
1D 0R
View PDF ↗
SummaryFull TextCommentsAnnotations

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.